Today’s healthcare and pharmaceutical companies are in a position to reap significant gains from accelerated digital innovation. This progress continues to push the frontiers of what practitioners can achieve for society – from rapid onboarding of new patients to remote televisits and proactively diagnosing conditions in advance.

They say that necessity is the mother of invention. While it is difficult to talk about any silver lining to what has been a medical and humanitarian disaster, it is hoped that the digital transformation initiatives that were triggered and – in some cases – accelerated by the pandemic will yield benefits that will long outlast Covid-19.

This report explores where digital strategies and investment are focused by healthcare and pharma companies, and the challenges that the sector continues to face. It also looks at where companies defined as industry leaders are focusing to gain a competitive advantage in a fast-changing world.